Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseasesHighly differentiated, ...
Insecticides Market To Reach USD 12.4 Billion By 2030, Growing At A 4.80% CAGR - Credence Research
The global insecticides market is experiencing steady growth, driven by the increasing demand for effective pest control ...
News-Medical.Net5d
The CDMO Surge: Why Pharma Is Outsourcing More Than Ever
Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...
VITRAKVI Maintains Market Leadership Across the 7MM Amid Growing TRK Inhibitor Competition | DelveInsight
DelveInsight's "VITRAKVI Market Size, Forecast, and Market Insight Report" highlights the details around VITRAKVI, a TRK, ...
Opko Health, Entera Bio enter collaboration agreement for GLP-1/glucagon peptide
OPKO Health (OPK) and Entera Bio (ENTX) entered into a collaboration and license agreement to advance into the clinic the first oral dual ...
Global Nanocellulose Market By Growth, Industry Size, Trends, Shares, By Top Players, And Forecast 2033
Emergen Research Logo As global demand for bio-based materials continues to rise, nanocellulose is poised to play a crucial role in various ...
Surf Bio Appoints Industry Veteran Doug Hecker as Head of Technical Operations
Surf Bio, a biopharmaceutical company transforming the delivery of antibodies and biologics, announced today the appointment of Doug Hecker as Head of Technical Operations. With over 30 years of ...
ROZLYTREK's Market Growth Reflects Transforming Treatment for NTRK and ROS1-Positive Cancers | DelveInsight
DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an ...
Finanznachrichten11d
DelveInsight Business Research, LLP: TAGRISSO Sets the Stage for Market Leadership in Oncology with Strong Growth Prospects | DelveInsight
The recommended TAGRISSO dosage is 80 mg once daily, taken with or without food, and continued until disease progression or unacceptable toxicity occurs. Learn more about TAGRISSO projected market ...